Chemoinformaics analysis of 3,7-Octadien-2-one, (E)-
| Molecular Weight | 124.183 | nRot | 4 |
| Heavy Atom Molecular Weight | 112.087 | nRig | 3 |
| Exact Molecular Weight | 124.089 | nRing | 0 |
| Solubility: LogS | -1.576 | nHRing | 0 |
| Solubility: LogP | 1.705 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 22.1635 |
| nHD | 0 | BPOL | 12.9065 |
| QED | 0.524 |
| Synth | 3.139 |
| Natural Product Likeliness | 2.013 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.382 |
| MDCK | 0.000027 |
| BBB | 0.968 |
| PPB | 0.719002 |
| VDSS | 0.814 |
| FU | 0.218452 |
| CYP1A2-inh | 0.27 |
| CYP1A2-sub | 0.583 |
| CYP2c19-inh | 0.129 |
| CYP2c19-sub | 0.493 |
| CYP2c9-inh | 0.02 |
| CYP2c9-sub | 0.844 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.078 |
| CYP3a4-sub | 0.21 |
| CL | 11.151 |
| T12 | 0.872 |
| hERG | 0.005 |
| Ames | 0.23 |
| ROA | 0.029 |
| SkinSen | 0.926 |
| Carcinogencity | 0.179 |
| EI | 0.994 |
| Respiratory | 0.658 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.956486 |